News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,251 Results
Type
Article (41092)
Company Profile (264)
Press Release (658895)
Section
Business (205621)
Career Advice (2022)
Deals (35586)
Drug Delivery (97)
Drug Development (81557)
Employer Resources (169)
FDA (16297)
Job Trends (14918)
News (347608)
Policy (32957)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2585)
Accelerated approval (2)
Adcomms (21)
Allergies (80)
Alliances (50103)
ALS (76)
Alzheimer's disease (1338)
Antibody-drug conjugate (ADC) (100)
Approvals (16274)
Artificial intelligence (215)
Autoimmune disease (10)
Automation (14)
Bankruptcy (359)
Best Places to Work (11684)
BIOSECURE Act (20)
Biosimilars (97)
Biotechnology (188)
Bladder cancer (51)
Brain cancer (23)
Breast cancer (234)
Cancer (1807)
Cardiovascular disease (134)
Career advice (1684)
Career pathing (28)
CAR-T (132)
Cell therapy (383)
Cervical cancer (13)
Clinical research (65770)
Collaboration (708)
Compensation (398)
Complete response letters (20)
COVID-19 (2611)
CRISPR (32)
C-suite (180)
Cystic fibrosis (98)
Data (1715)
Decentralized trials (2)
Denatured (16)
Depression (36)
Diabetes (225)
Diagnostics (6337)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (106)
Drug pricing (97)
Drug shortages (24)
Duchenne muscular dystrophy (67)
Earnings (85905)
Editorial (29)
Employer branding (21)
Employer resources (145)
Events (112020)
Executive appointments (589)
FDA (17275)
Featured Employer (53)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (637)
Gene editing (87)
Generative AI (19)
Gene therapy (264)
GLP-1 (670)
Government (4466)
Grass and pollen (4)
Guidances (46)
Healthcare (18878)
Huntington's disease (23)
IgA nephropathy (19)
Immunology and inflammation (93)
Indications (24)
Infectious disease (2731)
Inflammatory bowel disease (129)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (70)
Interviews (312)
IPO (16538)
IRA (41)
Job creations (3668)
Job search strategy (1435)
Kidney cancer (9)
Labor market (26)
Layoffs (448)
Leadership (14)
Legal (7952)
Liver cancer (69)
Lung cancer (264)
Lymphoma (119)
Machine learning (2)
Management (57)
Manufacturing (253)
MASH (57)
Medical device (13356)
Medtech (13361)
Mergers & acquisitions (19454)
Metabolic disorders (585)
Multiple sclerosis (59)
NASH (16)
Neurodegenerative disease (73)
Neuropsychiatric disorders (23)
Neuroscience (1768)
NextGen: Class of 2025 (6561)
Non-profit (4505)
Northern California (2219)
Now hiring (35)
Obesity (322)
Opinion (204)
Ovarian cancer (61)
Pain (69)
Pancreatic cancer (70)
Parkinson's disease (117)
Partnered (18)
Patents (181)
Patient recruitment (81)
Peanut (48)
People (57318)
Pharmaceutical (65)
Pharmacy benefit managers (18)
Phase I (20513)
Phase II (28944)
Phase III (21583)
Pipeline (809)
Podcasts (44)
Policy (104)
Postmarket research (2579)
Preclinical (8680)
Press Release (71)
Prostate cancer (84)
Psychedelics (31)
Radiopharmaceuticals (248)
Rare diseases (341)
Real estate (5988)
Recruiting (64)
Regulatory (22346)
Reports (43)
Research institute (2355)
Resumes & cover letters (350)
Rett syndrome (2)
RNA editing (1)
RSV (37)
Schizophrenia (60)
Series A (116)
Series B (69)
Service/supplier (11)
Sickle cell disease (51)
Southern California (1899)
Special edition (13)
Sponsored (29)
Startups (3629)
State (2)
Stomach cancer (11)
Supply chain (56)
The Weekly (27)
United States (19555)
Vaccines (645)
Venture capitalists (34)
Webinars (12)
Weight loss (218)
Women's health (30)
Worklife (13)
Date
Today (168)
Last 7 days (760)
Last 30 days (2956)
Last 365 days (34584)
2025 (5738)
2024 (35504)
2023 (40356)
2022 (51514)
2021 (56054)
2020 (54432)
2019 (46866)
2018 (35316)
2017 (32505)
2016 (31870)
2015 (37942)
2014 (31700)
2013 (26720)
2012 (28898)
2011 (29591)
2010 (27584)
Location
Africa (733)
Alabama (48)
Alaska (7)
Arizona (212)
Arkansas (12)
Asia (38288)
Australia (6236)
California (5061)
Canada (1763)
China (419)
Colorado (232)
Connecticut (241)
Delaware (112)
Europe (82319)
Florida (742)
Georgia (172)
Idaho (57)
Illinois (465)
India (20)
Indiana (276)
Iowa (7)
Japan (126)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (59)
Maryland (794)
Massachusetts (3875)
Michigan (201)
Minnesota (355)
Mississippi (2)
Missouri (71)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (61)
New Jersey (1440)
New Mexico (27)
New York (1445)
North Carolina (875)
North Dakota (8)
Northern California (2219)
Ohio (180)
Oklahoma (13)
Oregon (33)
Pennsylvania (1146)
Puerto Rico (6)
Rhode Island (23)
South America (1112)
South Carolina (13)
South Dakota (1)
Southern California (1899)
Tennessee (83)
Texas (738)
Utah (156)
Virginia (117)
Washington D.C. (56)
Washington State (480)
West Virginia (3)
Wisconsin (44)
700,251 Results for "affinity biologicals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
REGENXBIO Announces Expansion of AFFINITY DUCHENNE® Trial to Include a New Cohort of Younger Patients
REGENXBIO Inc. (Nasdaq: RGNX) today announced it initiated enrollment in a new cohort of patients ages 1-3 in its Phase I/II AFFINITY DUCHENNE® trial to evaluate the safety and efficacy of RGX-202 in boys with Duchenne muscular dystrophy (Duchenne).
June 24, 2024
·
10 min read
Genetown
AffyImmune Announces Presentation on Affinity-Tuned CAR T Therapy AIC100 at ASCO 2024
AffyImmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced an abstract detailing its affinity-tuned CAR T therapy AIC100 will be presented at the American Society of Clinical Oncology 2024 Annual Meeting, held May 31-June 4, at McCormick Place Convention Center in Chicago, IL.
April 24, 2024
·
1 min read
Press Releases
MustGrow Signs Exclusive Distribution Agreement with Adjuvants Plus Inc. for Biological Product Line
February 11, 2025
·
8 min read
Press Releases
HCW Biologics Inc. Received NASDAQ Staff Determination Letter
December 23, 2024
·
4 min read
Press Releases
ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery
January 23, 2025
·
3 min read
Policy
Affinity Biosensors Receives FDA Clearance for the LifeScale AST System
Affinity Biosensors, a leading innovator in the field of healthcare diagnostics, announces that its groundbreaking LifeScale AST system has received FDA clearance.
April 3, 2024
·
3 min read
Genetown
AffyImmune Presents Preclinical Data on AIC100 Affinity-Tuned CAR T Targeting ICAM-1 in Additional Solid Tumor Types at AACR 2024
AffyImmune, a clinical-stage biopharmaceutical company committed to developing novel, first-in-class, affinity-tuned CAR T cell therapies, presented preclinical data on new indications for its lead program, AIC100, at the American Association for Cancer Research (AACR) Annual Meeting 2024.
April 9, 2024
·
2 min read
Manufacturing
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Business
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.
June 28, 2024
·
4 min read
Drug Development
REGENXBIO Announces Dose Escalation in AFFINITY DUCHENNE® Trial
REGENXBIO Inc. today announced that the first patient received RGX-202 at dose level 2 in the Phase I/II AFFINITY DUCHENNE® trial.
November 29, 2023
·
7 min read
1 of 70,026
Next
